« Back to Record
Citation APA

Hoeper, M. M., Scelsi, L., Grünig, E., Vizza, C. D., Chang, M., Colorado, P., Meier, C., Busse, D., Benza, R. L., Simonneau, G., Corris, P., Ghofrani, H. A., Klinger, J. J., Langleben, D., Naeije, R., Jansa, P., & Rosenkranz, S. (2017). RESPITE: Switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors. The European respiratory journal, 50(3), 02425. doi:10.1183/13993003.02425-2016


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/260498

Hoeper, M. M., Scelsi, L., Grünig, E., Vizza, C. D., Chang, M., Colorado, P., Meier, C., Busse, D., Benza, R. L., Simonneau, G., Corris, P., Ghofrani, H. A., Klinger, J. J., Langleben, D., Naeije, R., Jansa, P., & Rosenkranz, S. (2017). RESPITE: Switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors. The European respiratory journal, 50(3), 02425. doi:10.1183/13993003.02425-2016